Landscape inferred from gene expression data governs pluripotency in embryonic stem cells

Computational and Structural Biotechnology Journal
Xin Kang, Chunhe Li

Abstract

Embryonic stem cells (ESCs) can differentiate into diverse cell types and have the ability of self-renewal. Therefore, the study of cell fate decisions on embryonic stem cells has far-reaching significance for regenerative medicine and other biomedical fields. Mathematical models have been used to study emryonic stem cell differentiation. However, the underlying mechanisms of cell differentiation and lineage reprogramming remain to be elucidated. Especially, how to integrate the computational models with quantitative experimental data is still challenging. In this work, we developed a data-constrained modelling approach, and established a model of mouse embryonic stem cells. We used the truncated moment equations (TME) method to quantify the potential landscape of the ESC network. We identified two attractors on the landscape, which represent the embryonic stem cell (ESC) state and differentiated cell (DC) state, respectively, and quantified high dimensional biological paths for differentiation and reprogramming process. Through identifying the optimal combinations of gene targets based on a landscape control strategy, we offered some predictions about the key regulatory factors that govern the differentiation and reprogramming...Continue Reading

References

Mar 12, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Julio C DavilaJames Trosko
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anselme L PerrierLorenz Studer
Jun 13, 2006·Nature·Natalia IvanovaIhor R Lemischka
Feb 9, 2007·Differentiation; Research in Biological Diversity·Jian LiHongkui Deng
Apr 7, 2007·Developmental Biology·Sui HuangTariq Enver
Dec 22, 2007·Nature·Ian ChambersAustin Smith
Mar 19, 2008·The Journal of Chemical Physics·Xiang ZhouWeinan E
Mar 19, 2008·Genes & Development·Megan F ColeRichard A Young
May 24, 2008·Nature·Qi-Long YingAustin Smith
Oct 23, 2008·Cell Stem Cell·Qiao Zhou, Douglas A Melton
Oct 30, 2008·The Journal of Biological Chemistry·Xiaofei ZhangDuanqing Pei
Aug 26, 2009·Cell·Jose SilvaAustin Smith
Dec 3, 2009·Cell Stem Cell·Krishanu Saha, Rudolf Jaenisch
Dec 4, 2009·Nature·Thomas Graf, Tariq Enver
Apr 7, 2010·Cell Stem Cell·Debbie L C van den BergRaymond A Poot
Jun 11, 2010·Nature·Shinya Yamanaka, Helen M Blau
May 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jin WangErkang Wang
Dec 12, 2012·Cell Research·Jia-Chi Yeo, Huck-Hui Ng
May 7, 2013·The Journal of Physical Chemistry. B·Chen Liao, Ting Lu
Oct 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Mingyang LuEshel Ben-Jacob
Jun 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Bin Zhang, Peter G Wolynes
Aug 30, 2014·Physical Review Letters·Mingyang LuEshel Ben-Jacob
Sep 18, 2014·Proceedings of the National Academy of Sciences of the United States of America·Chunhe Li, Jin Wang
Jul 19, 2015·Cytokine & Growth Factor Reviews·Nicos A Nicola, Jeffrey J Babon
Feb 17, 2018·PLoS Computational Biology·Yen Ting LinDavit A Potoyan
Aug 4, 2018·PLoS Computational Biology·Margaret J TseElizabeth L Read
Aug 30, 2018·NPJ Systems Biology and Applications·Chunhe Li, Gabor Balazsi

❮ Previous
Next ❯

Citations

Oct 27, 2020·Computational and Structural Biotechnology Journal·Anne L PlantJeffrey Stinson

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

MATLAB

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.